Who
Robert Martin Emanuele
Director
Company insider
Files Form 4 as: Director, Artelo Biosciences; Senior VP, Development, Savara; V P, Business Development, Avanir Pharmaceuticals.
In numbers
- Trades disclosed
- 34
- Buys
- 1
- Sells
- 1
- Bought
- $8,990
- Sold
- $25K
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 25 May 2006
- Last trade
- 17 Jul 2026
- Last filed
- 21 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jul 2026filed 21 Jul 2026 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —136 at $0.00 | filing |
| 17 Jul 2026filed 21 Jul 2026 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —136 at $0.00 | filing |
| 30 Jan 2026filed 2 Feb 2026 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —292 at $0.00 | filing |
| 30 Jan 2026filed 2 Feb 2026 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —292 at $0.00 | filing |
| 20 Dec 2024filed 23 Dec 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,750 at $0.00 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —834 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —1,167 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —8,034 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —667 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —667 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —667 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —1,083 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —834 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,167 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,034 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —667 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —667 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —667 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,083 | filing |
| 4 Aug 2023filed 8 Aug 2023 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,083 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.